RXN Company Financials

RXN 
$19
*  
0.20
  negative  
1.06%
Get RXN Alerts
*Delayed - data as of May 23, 2013 
Exchange: NYSE
Industry: Technology
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time


Annual Income Statement (values in 000's)

Period Ending: Trend 3/31/2013 3/31/2012 3/31/2011 3/31/2010
Total Revenue
$2,005,100 $1,944,200 $1,674,900 $1,510,000
Cost of Revenue
$1,273,700 $1,254,100 $1,082,400 $994,400
Gross Profit
$731,400 $690,100 $592,500 $515,600
Operating Expenses
Research and Development
$0 $0 $0 $0
Sales, General and Admin.
$416,300 $387,100 $326,700 $297,700
Non-Recurring Items
$8,600 $6,800 $0 $6,800
Other Operating Items
$51,100 $50,900 $48,600 $49,700
Operating Income
$255,400 $245,300 $217,200 $161,400
Add'l income/expense items
($26,900) ($24,200) ($99,700) $151,400
Earnings Before Interest and Tax
$228,500 $221,100 $117,500 $312,800
Interest Expense
$153,300 $176,200 $180,800 $194,200
Earnings Before Tax
$75,200 $44,900 ($63,300) $118,600
Income Tax
$20,300 $9,400 ($10,200) $30,500
Minority Interest
$0 $0 $0 $0
Equity Earnings/Loss Unconsolidated Subsidiary
$0 $0 $0 $0
Net Income-Cont. Operations
$54,900 $35,500 ($53,100) $255,900
Net Income
$50,100 $29,900 ($51,300) $88,100
Net Income Applicable to Common Shareholders
$50,100 $29,900 ($51,300) $88,100

See also: Company Financials data entry page